figshare
Browse
13075_2015_866_MOESM2_ESM.pdf (521.56 kB)

Additional file 2: of Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice

Download (521.56 kB)
journal contribution
posted on 2015-12-10, 05:00 authored by Alba Llop-Guevara, Mónica Porras, Carla Cendón, Irene Di Ceglie, Francesco Siracusa, Federica Madarena, Vagelis Rinotas, Lluís Gómez, Peter van Lent, Eleni Douni, Hyun Dong Chang, Thomas Kamradt, Juan Román
Clinical and immunological comparison of acute versus chronic glucose-6-phosphate isomerase ( G6PI )-induced arthritis model in mice. a Diagram summarizing the experimental protocol followed in Figs. 1, 2, 3, 4 and 5 (see “Methods” for more details). b Time course for arthritis scores clearly showing moderate and acute arthritis in G6PI-immunized mice, and severe and chronic arthritis in T regulatory cell (Treg)-depleted and G6PI-immunized mice. c Proportion of CD25hiFoxp3+ Treg cells in CD3+CD4+ cells at the time of immunization (day 0). d Numbers of total cells from inguinal lymph nodes and e leucocyte counts in peripheral blood at day 6 post-immunization. f Cytokine secretion by splenocytes isolated on day 31 and stimulated in vitro with 20 μg/ml G6PI for 72 h. Graphs show mean (± standard error of the mean) for 3–6 mice/group, *p <0.05 versus naive control, # p <0.05 versus G6PI-immunized mice. s.c. subcutaneous administration, i.v. intravenous administration, i.p. intraperitoneal administration, p.o. oral administration, QD one dose a day. (PDF 521 kb)

Funding

Seventh Framework Programme (BE)

History

Usage metrics

    Arthritis Research & Therapy

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC